Department of Pharmacy, TriStar Skyline Medical Center, 3441 Dickerson Pike, 37207, Nashville, TN, USA.
Int J Clin Pharm. 2022 Jun;44(3):741-748. doi: 10.1007/s11096-022-01405-8. Epub 2022 Apr 21.
Background While various strategies for antibiotic restrictions have been validated, their impacts are not well described in smaller, non-teaching facilities. Fluoroquinolones are an appropriate target for restriction based on their propensity for overuse and potential for causing "collateral damage." Aim Evaluate the impact of a multifaceted approach to decreasing fluoroquinolone use on consumption of fluoroquinolones and alternative antibiotics at a smaller, non-teaching facility. Method Prospective, interrupted time series analysis conducted at a single 288-bed, non-teaching hospital with 71 adult ICU beds comparing antibiotic consumption measured monthly by defined daily doses per 1000 adjusted patient days (DDD/1000 APD) prior to intervention (January 2011 to August 2014) to short-term (October 2014 to December 2015) and long-term (January 2018 to December 2019) periods following intervention. Results An increase in downward trends of fluoroquinolone use was observed from prior to intervention (-0.49 DDD/1000 APD) to the short-term period (-1.13 DDD/1000 APD) and to a greater extent in the long-term period following the intervention (-1.32 DDD/1000 APD). Fluoroquinolone consumption decreased from 100.20 DDD/1000 APD in August 2014 to 73.96 DDD/1000 APD in the short-term and 14.89 DDD/1000 APD in the long-term intervention period. Levofloxacin susceptibility for Pseudomonas aeruginosa increased from 61% to 2014 to 83% in 2018. No deleterious effects on Pseudomonas aeruginosa susceptibilities were observed for alternative antibiotics. Conclusion A multifaceted approach aimed at decreasing fluoroquinolone use at a community hospital led to a sustained decrease in consumption and a substantial increase in levofloxacin susceptibility to Pseudomonas aeruginosa.
虽然已经验证了各种抗生素限制策略,但它们在较小的非教学机构中的影响尚未得到很好的描述。氟喹诺酮类药物由于过度使用的倾向和潜在的“附带损害”,是限制使用的合适目标。目的:评估在一个较小的非教学机构中,采用多方面方法减少氟喹诺酮类药物使用对氟喹诺酮类药物和替代抗生素消耗的影响。方法:在一家 288 张床位的非教学医院进行前瞻性、中断时间序列分析,该医院有 71 张成人 ICU 床位。在干预前(2011 年 1 月至 2014 年 8 月),通过每月每 1000 个调整患者日(DDD/1000APD)测量抗生素消耗,与短期(2014 年 10 月至 2015 年 12 月)和长期(2018 年 1 月至 2019 年 12 月)干预后进行比较。结果:在干预前(-0.49 DDD/1000 APD)到短期(-1.13 DDD/1000 APD)期间,观察到氟喹诺酮类药物使用的下降趋势增加,在干预后的长期期间增加幅度更大(-1.32 DDD/1000 APD)。氟喹诺酮类药物的消耗从 2014 年 8 月的 100.20 DDD/1000 APD 减少到短期的 73.96 DDD/1000 APD 和长期的 14.89 DDD/1000 APD。铜绿假单胞菌对左氧氟沙星的敏感性从 2014 年的 61%增加到 2018 年的 83%。替代抗生素对铜绿假单胞菌敏感性没有观察到有害影响。结论:在社区医院采用多方面方法减少氟喹诺酮类药物的使用,导致消耗持续减少,铜绿假单胞菌对左氧氟沙星的敏感性显著增加。